Literature DB >> 17459753

Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.

Nirmala Devi Baskaran1, Gin Gin Gan, Kamarulzaman Adeeba, I-Ching Sam.   

Abstract

OBJECTIVES: This study was initiated to determine the local profile of blood culture isolates and antibiotic sensitivities in febrile neutropenic patients following chemotherapy, and to establish if any modifications to treatment guidelines are necessary.
DESIGN: A total of 116 episodes of febrile neutropenia admitted to the adult hematology ward at a university medical center in Malaysia were studied retrospectively from January 2004 to January 2005.
RESULTS: The study showed 43.1% of febrile neutropenic episodes had established bacteremia. Gram-negative bacteria accounted for 60.3% of isolates. Sensitivities of Gram-negative bacteria to the antibiotics recommended in the Infectious Diseases Society of America (IDSA) guidelines were 86.1-97.2%. Coagulase-negative staphylococci were the most common Gram-positive organisms isolated (23.3%). The majority of these were methicillin-resistant.
CONCLUSIONS: Carbapenem monotherapy, as recommended in the 2002 IDSA guidelines, is effective treatment for the infections most often encountered at our center. Combination therapy with an aminoglycoside should be considered when using ceftazidime, cefepime or piperacillin-tazobactam, particularly in high-risk patients. Vancomycin should be used if a Gram-positive organism is suspected or isolated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459753     DOI: 10.1016/j.ijid.2007.02.002

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  22 in total

1.  Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.

Authors:  Fekade Bruck Sime; Uwe Hahn; Morgyn S Warner; Ing Soo Tiong; Michael S Roberts; Jeffrey Lipman; Sandra L Peake; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.

Authors:  J A Greenberg; M Z David; D L Pitrak; J B Hall; J P Kress
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

3.  Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Yun-Hee Chun; In-Ho Kwon; Won Kim; Kyung Soo Lim; Tae Won Kim; Kyoo-Hyung Lee
Journal:  Support Care Cancer       Date:  2010-06-16       Impact factor: 3.603

4.  Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India.

Authors:  Indranil Ghosh; Vinod Raina; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Sanjay Thulkar; Arti Kapil
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

5.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

Review 6.  Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.

Authors:  Mical Paul; Dafna Yahav; Assaf Bivas; Abigail Fraser; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

7.  Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.

Authors:  Yeter Düzenli Kar; Zeynep Canan Özdemir; Özcan Bör
Journal:  Turk Pediatri Ars       Date:  2017-12-01

8.  Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.

Authors:  Arun B Karanwal; Bharat J Parikh; Parijat Goswami; Harsha P Panchal; Bhavesh B Parekh; Kaushal B Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04

9.  Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.

Authors:  Seema Irfan; Faiza Idrees; Vikram Mehraj; Faizah Habib; Salman Adil; Rumina Hasan
Journal:  BMC Infect Dis       Date:  2008-06-09       Impact factor: 3.090

10.  Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center.

Authors:  Jae-Cheol Kwon; Si-Hyun Kim; Jae-Ki Choi; Sung-Yeon Cho; Yeon-Joon Park; Sun Hee Park; Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo
Journal:  Infect Chemother       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.